Charles Jensen, Ph.D., has been appointed director of Drug Metabolism and Pharmacokinetics (DMPK) at AMRI. He reports to Bruce J. Sargent, Ph.D., senior vice president of Drug Discovery. Dr. Jensen has more than 20 years of experience working in the fields of drug metabolism and toxicology in the pharmaceutical industry. He spent 15 years at Eli Lilly and Co., where he ultimately became senior study director for drug development services for in vitro technologies. Prior to Lilly, Dr. Jensen wor...